Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19026986rdf:typepubmed:Citationlld:pubmed
pubmed-article:19026986lifeskim:mentionsumls-concept:C1333572lld:lifeskim
pubmed-article:19026986lifeskim:mentionsumls-concept:C0206131lld:lifeskim
pubmed-article:19026986lifeskim:mentionsumls-concept:C0442805lld:lifeskim
pubmed-article:19026986lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:19026986lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:19026986pubmed:issue2lld:pubmed
pubmed-article:19026986pubmed:dateCreated2008-12-8lld:pubmed
pubmed-article:19026986pubmed:abstractTextObesity is associated with a low-grade inflammation in adipose tissue resulting from increased production of pro-inflammatory cytokines and which can subsequently contribute to the development of insulin resistance. However, the mechanisms underlying the transcriptional regulation of pro-inflammatory genes are still unclear. Here we show that tumor necrosis factor (TNF)-alpha treatment attenuated Akt-dependent phosphorylation of Foxo1 and enhanced transcriptional activity of Foxo1. We found that Foxo1 increased the expression of CCAAT/enhancer binding protein (C/EBPbeta, a positive regulator of monocyte chemoattractant protein (MCP)-1 and interleukin (IL)-6 genes, through directly binding to its promoter. Furthermore, knockdown of Foxo1 as well as C/EBPbeta inhibits TNF-alpha-induced expression of MCP-1 and IL-6 in 3T3-L1 adipocytes. These findings suggest that activation of Foxo1 triggered by TNF-alpha up-regulates the expression of C/EBPbeta in 3T3-L1 adipocytes, thereby leading to an increased production of pro-inflammatory cytokines, MCP-1 and IL-6.lld:pubmed
pubmed-article:19026986pubmed:languageenglld:pubmed
pubmed-article:19026986pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19026986pubmed:citationSubsetIMlld:pubmed
pubmed-article:19026986pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19026986pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19026986pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19026986pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19026986pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19026986pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19026986pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19026986pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19026986pubmed:statusMEDLINElld:pubmed
pubmed-article:19026986pubmed:monthJanlld:pubmed
pubmed-article:19026986pubmed:issn1090-2104lld:pubmed
pubmed-article:19026986pubmed:authorpubmed-author:LuxWWlld:pubmed
pubmed-article:19026986pubmed:authorpubmed-author:DaitokuHiroak...lld:pubmed
pubmed-article:19026986pubmed:authorpubmed-author:FukamizuAkiyo...lld:pubmed
pubmed-article:19026986pubmed:issnTypeElectroniclld:pubmed
pubmed-article:19026986pubmed:day9lld:pubmed
pubmed-article:19026986pubmed:volume378lld:pubmed
pubmed-article:19026986pubmed:ownerNLMlld:pubmed
pubmed-article:19026986pubmed:authorsCompleteYlld:pubmed
pubmed-article:19026986pubmed:pagination290-5lld:pubmed
pubmed-article:19026986pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:19026986pubmed:meshHeadingpubmed-meshheading:19026986...lld:pubmed
pubmed-article:19026986pubmed:meshHeadingpubmed-meshheading:19026986...lld:pubmed
pubmed-article:19026986pubmed:meshHeadingpubmed-meshheading:19026986...lld:pubmed
pubmed-article:19026986pubmed:meshHeadingpubmed-meshheading:19026986...lld:pubmed
pubmed-article:19026986pubmed:meshHeadingpubmed-meshheading:19026986...lld:pubmed
pubmed-article:19026986pubmed:meshHeadingpubmed-meshheading:19026986...lld:pubmed
pubmed-article:19026986pubmed:meshHeadingpubmed-meshheading:19026986...lld:pubmed
pubmed-article:19026986pubmed:meshHeadingpubmed-meshheading:19026986...lld:pubmed
pubmed-article:19026986pubmed:meshHeadingpubmed-meshheading:19026986...lld:pubmed
pubmed-article:19026986pubmed:meshHeadingpubmed-meshheading:19026986...lld:pubmed
pubmed-article:19026986pubmed:meshHeadingpubmed-meshheading:19026986...lld:pubmed
pubmed-article:19026986pubmed:meshHeadingpubmed-meshheading:19026986...lld:pubmed
pubmed-article:19026986pubmed:meshHeadingpubmed-meshheading:19026986...lld:pubmed
pubmed-article:19026986pubmed:meshHeadingpubmed-meshheading:19026986...lld:pubmed
pubmed-article:19026986pubmed:meshHeadingpubmed-meshheading:19026986...lld:pubmed
pubmed-article:19026986pubmed:meshHeadingpubmed-meshheading:19026986...lld:pubmed
pubmed-article:19026986pubmed:meshHeadingpubmed-meshheading:19026986...lld:pubmed
pubmed-article:19026986pubmed:meshHeadingpubmed-meshheading:19026986...lld:pubmed
pubmed-article:19026986pubmed:year2009lld:pubmed
pubmed-article:19026986pubmed:articleTitleFoxo1 increases pro-inflammatory gene expression by inducing C/EBPbeta in TNF-alpha-treated adipocytes.lld:pubmed
pubmed-article:19026986pubmed:affiliationCenter for Tsukuba Advanced Research Alliance, Graduate School of Life and Environmental Sciences, University of Tsukuba, 1-1-1 Tennoudai, Tsukuba 305-8577, Japan.lld:pubmed
pubmed-article:19026986pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:19026986pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:12608entrezgene:pubmedpubmed-article:19026986lld:entrezgene
entrez-gene:56458entrezgene:pubmedpubmed-article:19026986lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:19026986lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:19026986lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19026986lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19026986lld:pubmed